besremi (ropeginterferon alfa-2b-njft) injection for polycythemia vera (pv)
Published 2 years ago • 3.3K plays • Length 22:39Download video MP4
Download video MP3
Similar videos
-
1:56
5-year follow up results of long-term use of ropeginterferon alfa-2b in polycythemia vera
-
1:29
ropeginterferon alfa-2b for polycythemia vera: impacts and considerations
-
21:35
besremi® (ropeginterferon alfa-2b-njft) instructions for use
-
1:29
besremi (ropeginterferon alfa-2b-njft)- polycythemia vera
-
9:56
discover how besremi® (ropeginterferon alfa-2b-njft) works to target the source
-
1:49
current and future therapies for pv: ropeginterferon alfa-2b
-
2:40
safety and efficacy of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis
-
13:46
taking charge of my treatment: susan’s story
-
12:32
taking charge of my treatment: kevin's story
-
16:41
ropeginterferon alfa-2b for the treatment of low-risk patients with polycythemia vera
-
5:17
determining the potential of ropeginterferon alfa-2b in polycythemia vera
-
12:49
taking charge of my treatment: cheri's story
-
10:32
10 facts mpn patients need to know about fda approval of ropegylated interferon alpha2b (besremi).
-
3:19
targeting jak2 v617f vaf in polycythemia vera & the efficacy of ropeginterferon alfa-2b
-
0:39
switching from pegasys to besremi
-
1:39
upcoming agents in et and pv
-
7:42
low-pv interim analysis: ropeginterferon versus phlebotomy in low-risk polycythemia vera
-
13:25
taking charge of my treatment: gary's story
-
3:02
pilot study of ropeginterferon in early myelofibrosis